Overall rank by patents
#24,756
of 50,000 tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 3 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: F41B (WEAPONS FOR PROJECTING MISSILES WITHOUT USE OF EXPLOSIVE OR COMBUSTIBLE PROPELLANT CHARGE; WEAPONS NOT OTHERWISE PROVIDED FOR).
The verdict
According to USPTO PatentsView, Maruzen ranks #24,756 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 3 technology areas.
USPTO PatentsView assignee plate
Corpus R24756 · Foreign Corporation #24,756 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: MAIA Pharmaceuticals, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Maruzen · this assignee
20 score
3D Lighting Innovati… · lowest
7 score
What this shows Maruzen's Innovation Score is 19.7/100 (top 94% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Maruzen Company Limited is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under F41B (WEAPONS FOR PROJECTING MISSILES WITHOUT USE OF EXPLOSIVE OR COMBUSTIBLE PROPELLANT CHARGE; WEAPONS NOT OTHERWISE PROVIDED FOR). Peak complete grant year is 2017 (4 grants) versus a trough of 1 in 2016. By volume, Maruzen sits between MAIA Pharmaceuticals, Inc. and Maxine M. Thompson Trust.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
MAIA PHARMACEUTICALS, INC.
11 patents
MAINTECH CO., LTD.
11 patents
MANTA SLEEP LLC
11 patents
MARKWEST ENERGY PARTNERS, L.P.
11 patents
MASARYKOVA UNIVERZITA
11 patents
MASSACHUSETTS GENERAL HOSPITAL
11 patents
MATTUR HOLDINGS, INC.
11 patents
MAXINE M. THOMPSON TRUST
11 patents
MARUZEN COMPANY LIMITED
11 patents
What this shows Maruzen holds 11 patents at rank #24,731, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #24,731 in granted patent volume.
Other assignees with the most granted patents in Maruzen's primary technology class.
Maruzen's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
20 Top 94% higher than 6% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 18.2% |
| 2016 | 1 | 9.1% |
| 2017 | 4 | 36.4% |
| 2019 | 1 | 9.1% |
| 2020 | 2 | 18.2% |
| 2021 | 1 | 9.1% |
Top 3 of 3 technology areas
Overall rank by patents
#24,756
of 50,000 tracked assignees
19.7 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.